Physician

Laura W Salama, MD

According to 2025 Medicare claims, Laura Salama, MD (NPI: 1871026583) practices hematology/oncology in the Portland-South Portland, ME market, with the plurality of this provider's patient population coming from York, ME. This provider's primary affiliated billing organization is MAINE CENTER FOR CANCER MEDICINE & BLOOD DISORDERS, P.A. (NPI: 1205896107; TIN: 010357684) and primary practice location at 04043-6078. Salama is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), Aledade 205 New England MSSP Enhanced (ACO ID: A5370), Dartmouth Health Performance Network, LLC (ACO ID: A5414), and Aledade 201 National MSSP (ACO ID: A5522), participating under the MSSP model.

Salama's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 100 traditional Medicare patients, billed 5,730 HCPCS/CPT codes, and received $37,287 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 241 prescription claims across 62 beneficiaries totaling $138,122 in drug costs, led by Letrozole (Letrozole). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,041 to $138,122. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.